UK markets close in 43 minutes

Adamis Pharmaceuticals Corp (CY3.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
2.90000.0000 (0.00%)
As of 08:36AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-31,925
-26,478
-45,828
-49,391
-27,513
Depreciation & amortisation
1,475
1,484
1,436
2,329
2,945
Deferred income taxes
-
-
-
-
0
Stock-based compensation
138.192
-340.27
1,983
4,100
5,868
Change in working capital
882.188
-1,341
-10,799
6,974
-616.42
Accounts receivable
-571.543
-238.493
-573.344
324.84
-745.149
Inventory
-1,549
-820.171
-236.153
-1,774
24.763
Accounts payable
2,498
3,934
1,909
-388.375
574.51
Other working capital
-31,868
-26,581
-39,009
-21,602
-22,752
Other non-cash items
-485.929
1,255
6,212
14,389
18.46
Net cash provided by operating activities
-31,052
-25,901
-37,785
-20,901
-19,886
Cash flows from investing activities
Investments in property, plant and equipment
-816.104
-680.417
-1,223
-700.468
-2,866
Other investing activities
5,196
4,091
1,408
-
-
Net cash used for investing activities
4,494
3,484
282.737
-946.214
-2,866
Cash flows from financing activities
Debt repayment
-
-
-
-90.62
-496.79
Common stock issued
3,331
0
51,750
18,228
13,800
Other financing activities
-
-15
-3,331
-1,437
-1,012
Net cash used provided by (used for) financing activities
285
285
56,037
19,983
12,291
Net change in cash
-26,316
-22,132
16,433
-1,955
-10,461
Cash at beginning of period
28,762
23,251
6,749
8,418
19,272
Cash at end of period
2,446
1,111
23,251
6,749
8,811
Free cash flow
Operating cash flow
-31,052
-25,901
-37,785
-20,901
-19,886
Capital expenditure
-816.104
-680.417
-1,223
-700.468
-2,866
Free cash flow
-31,868
-26,581
-39,009
-21,602
-22,752